← Open Payments lookup

LAURA BEAUFFORD: Open Payments

NPI 1619563343 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$853 in 43 payments from 12 companies in 2025. Trend: 2023 $104 · 2024 $320 · 2025 $853

Food & beverage: $853
CompanyPaymentsAmount
ABBVIE INC.15$244
Otsuka America Pharmaceutical, Inc.9$147
Axsome Therapeutics, Inc.2$141
Vanda Pharmaceuticals Inc.4$89
Janssen Pharmaceuticals, Inc2$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
E.R. Squibb & Sons, L.L.C.2$33
Corium, LLC3$32
Supernus Pharmaceuticals, Inc.1$20
Teva Pharmaceuticals USA, Inc.1$18

Products named: VRAYLAR, REXULTI, Auvelity, FANAPT, SPRAVATO, CAPLYTA, COBENFY, Azstarys.

Industry payments across TX — which companies pay providers there.